Empe Diagnostics

Keiretsu Forum NordicsPortfolio, Portfolio company

EMPE’s patented point-of-care diagnostic solutions brings down the diagnosis time from ~6 months to 60 minutes, which reduces the treatment cost up to 50% and help to reduce spread of antibiotic resistance. EMPE Diagnostics is an interdisciplinary R&D-based biotechnology company that develops rapid diagnostic solutions for infectious diseases with a special focus on Tuberculosis and Sexually Transmitted Infections. EMPE’s internationally unique rapid tests can correctly identify virus or bacteria and their antimicrobial resistance within 2 h. We primarily focus on Tuberculosis and provide confirmatory clinical results by developing visual signals without requiring special instruments.